Video
Unknown · 0:00
Adrien Verster (co-founder/CSO of Dyno Therapeutics) explains why gene therapy has stayed slow for decades despite huge hype, and argues that the core bottleneck — safely and precisely delivering genetic payloads to t...
Unknown · 0:00
Adrien Verster (co-founder/CSO of Dyno Therapeutics) explains why gene therapy has stayed slow for decades despite huge hype, and argues that the core bottleneck — safely and precisely delivering genetic payloads to t...
Redirecting...